Yu‐Yan Hwang

1.3k total citations
37 papers, 779 citations indexed

About

Yu‐Yan Hwang is a scholar working on Epidemiology, Hematology and Oncology. According to data from OpenAlex, Yu‐Yan Hwang has authored 37 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Hematology and 9 papers in Oncology. Recurrent topics in Yu‐Yan Hwang's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Viral-associated cancers and disorders (6 papers). Yu‐Yan Hwang is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Viral-associated cancers and disorders (6 papers). Yu‐Yan Hwang collaborates with scholars based in China, Hong Kong and United States. Yu‐Yan Hwang's co-authors include Yok‐Lam Kwong, Harinder Gill, Thomas S. Y. Chan, Ching‐Lung Lai, Wai‐Kay Seto, Man‐Fung Yuen, James Fung, Kevin Sze-Hang Liu, Danny Ka‐Ho Wong and Albert K. W. Lie and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

Yu‐Yan Hwang

36 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Yan Hwang China 14 391 307 138 110 110 37 779
Marianne Coste‐Burel France 17 316 0.8× 82 0.3× 350 2.5× 124 1.1× 55 0.5× 41 879
Vincent Pedergnana France 11 224 0.6× 68 0.2× 148 1.1× 21 0.2× 55 0.5× 21 679
Arne Sattler Germany 18 181 0.5× 33 0.1× 244 1.8× 91 0.8× 59 0.5× 32 1.2k
Julio García‐Suárez Spain 16 107 0.3× 47 0.2× 154 1.1× 176 1.6× 40 0.4× 37 650
Nobuyuki Goya Japan 12 108 0.3× 38 0.1× 167 1.2× 23 0.2× 55 0.5× 52 609
J Icart France 15 348 0.9× 97 0.3× 384 2.8× 12 0.1× 49 0.4× 37 805
J Trofe United States 15 159 0.4× 47 0.2× 539 3.9× 14 0.1× 120 1.1× 40 824
Thérèse Croughs United States 13 228 0.6× 15 0.0× 307 2.2× 93 0.8× 82 0.7× 16 1.1k
Shigeharu Uchida Japan 14 296 0.8× 225 0.7× 76 0.6× 163 1.5× 5 0.0× 45 694
A. Benedict Cosimi United States 8 182 0.5× 77 0.3× 102 0.7× 22 0.2× 21 0.2× 11 420

Countries citing papers authored by Yu‐Yan Hwang

Since Specialization
Citations

This map shows the geographic impact of Yu‐Yan Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Yan Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Yan Hwang more than expected).

Fields of papers citing papers by Yu‐Yan Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Yan Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Yan Hwang. The network helps show where Yu‐Yan Hwang may publish in the future.

Co-authorship network of co-authors of Yu‐Yan Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Yan Hwang. A scholar is included among the top collaborators of Yu‐Yan Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Yan Hwang. Yu‐Yan Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Sang Hwan, Hee Jeong Cho, Joonho Moon, et al.. (2024). The characteristics of Korean elderly multiple myeloma patients aged 80 years or over. The Korean Journal of Internal Medicine. 40(1). 115–123.
2.
Hwang, Yu‐Yan, et al.. (2023). Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy. Virology Journal. 20(1). 168–168. 5 indexed citations
3.
Hwang, Yu‐Yan, Bonnie Kho, June S. M. Lau, et al.. (2022). Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy. Annals of Hematology. 101(6). 1163–1172. 1 indexed citations
5.
Au-Yeung, Rex, et al.. (2021). Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease. Annals of Hematology. 101(1). 99–108. 2 indexed citations
6.
Chan, Thomas S. Y., Yu‐Yan Hwang, Pek‐Lan Khong, et al.. (2020). Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting. Hematological Oncology. 38(5). 726–736. 23 indexed citations
7.
Seto, Wai‐Kay, Thomas S. Y. Chan, Yu‐Yan Hwang, et al.. (2018). Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBV. Clinical Gastroenterology and Hepatology. 17(7). 1410–1412. 10 indexed citations
8.
9.
Seto, Wai‐Kay, Yu‐Yan Hwang, Danny Ka‐Ho Wong, et al.. (2016). Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study. Hepatology. 65(5). 1451–1461. 63 indexed citations
10.
Chan, Thomas S. Y., Ian Yeung, Yu‐Yan Hwang, et al.. (2015). Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine. Annals of Hematology. 94(6). 1043–1047. 13 indexed citations
11.
Gill, Harinder, Yu‐Yan Hwang, Thomas S. Y. Chan, et al.. (2014). Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab. Journal of Clinical Virology. 59(4). 255–258. 14 indexed citations
12.
Chan, Thomas S. Y., Yu‐Yan Hwang, Kelvin Kai‐Wang To, & Yok‐Lam Kwong. (2013). Sporopachydermia cereana fungaemia in refractory leukaemia presenting as breakthrough infection during micafungin therapy. Infection. 41(3). 715–717. 3 indexed citations
13.
Chan, Thomas S. Y., Harinder Gill, Yu‐Yan Hwang, et al.. (2013). Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients. Annals of Hematology. 93(3). 493–498. 17 indexed citations
14.
Leung, Anskar Y.H., Eric Tse, Yu‐Yan Hwang, et al.. (2013). Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced‐intensity conditioning second transplantation from the original donor. American Journal of Hematology. 88(6). 485–491. 9 indexed citations
15.
Hwang, Yu‐Yan, Nigel J. Trendell‐Smith, C.K. Yeung, & Yok‐Lam Kwong. (2012). Fatal Palmar-Plantar Erythrodysesthesia after Clofarabine and Cytarabine Chemotherapy. Acta Haematologica. 128(3). 151–153. 3 indexed citations
16.
Hwang, Yu‐Yan, Harinder Gill, Wing‐Yan Au, et al.. (2012). Post‐transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment. Clinical Transplantation. 26(5). 679–683. 16 indexed citations
17.
Hwang, Yu‐Yan & Raymond Liang. (2010). Hepatitis C in Haematological Patients. PubMed. 2010. 1–4. 5 indexed citations
18.
Hwang, Yu‐Yan, Eric Tse, Jason C. C. So, Thomas S. K. Wan, & Yok‐Lam Kwong. (2009). Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate. American Journal of Hematology. 84(5). 302–305. 2 indexed citations
19.
Hwang, Yu‐Yan, et al.. (2008). Massive rectal bleeding in a patient with a history of hepatocellular carcinoma: Figure 1. Gut. 57(10). 1412–1412. 1 indexed citations
20.
Hwang, Yu‐Yan, et al.. (2002). Measurements of the characteristics of indoor penetration loss. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026